1. Home
  2. DCO vs GPCR Comparison

DCO vs GPCR Comparison

Compare DCO & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$95.85

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$68.73

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
GPCR
Founded
1849
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
DCO
GPCR
Price
$95.85
$68.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$117.80
$97.90
AVG Volume (30 Days)
100.3K
2.4M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$806,224,000.00
N/A
Revenue This Year
$6.11
N/A
Revenue Next Year
$8.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.17
N/A
52 Week Low
$51.76
$13.22
52 Week High
$101.47
$94.90

Technical Indicators

Market Signals
Indicator
DCO
GPCR
Relative Strength Index (RSI) 60.22 68.61
Support Level $91.51 $61.87
Resistance Level $99.23 $72.00
Average True Range (ATR) 2.99 7.83
MACD 0.69 0.38
Stochastic Oscillator 78.17 48.10

Price Performance

Historical Comparison
DCO
GPCR

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: